https://scholars.lib.ntu.edu.tw/handle/123456789/484017
標題: | Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells | 作者: | YU-YUN SHAO MIN-SHU HSIEH Wang, Han Yu Li, Yong Shi Lin, Hang Hsu, Hung Wei Huang, Chung Yi CHIH-HUNG HSU ANN-LII CHENG |
關鍵字: | Angiogenesis | Core protein | Hepatitis C virus | Hepatocellular carcinoma;Angiogenesis; Core protein; Hepatitis C virus; Hepatocellular carcinoma | 公開日期: | 17-十月-2017 | 卷: | 8 | 期: | 49 | 來源出版物: | Oncotarget | 摘要: | © Shao et al. Increased angiogenic activity has been demonstrated in hepatitis C virus (HCV)- related hepatocellular carcinoma (HCC), but the mechanism was unclear. To study the role of HCV core protein, we used tube formation and Matrigel plug assays to assess the proangiogenic activity of an HCC cell line, HuH7, and 2 of its stable clones-HuH7-corehigh and HuH7-core-low, with high and low HCV core protein expression, respectively. In both assays, HuH7-core-high and HuH7-core-low cells dose-dependently induced stronger angiogenesis than control cells. HuH7 cells with HCV core protein expression showed increased mRNA and protein expression of vascular endothelial growth factor (VEGF). VEGF inhibition by bevacizumab reduced the proangiogenic activity of HuH7- core-high cells. The promotor region of VEGF contains the binding site of activator protein-1 (AP-1). Compared with controls, HuH7-core-high cells had an increased AP-1 activity and nuclear localization of phospho-c-jun. AP-1 inhibition using either RNA knockdown or AP-1 inhibitors reduced the VEGF mRNA expression and the proangiogenic activity of HuH7-core-high cells. Among 131 tissue samples from HCC patients, HCV-related HCC revealed stronger VEGF expression than did hepatitis B virus-related HCC. In conclusion, increased VEGF expression through AP-1 activation is a crucial mechanism underlying the proangiogenic activity of the HCV core protein in HCC cells. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/484017 | ISSN: | 1949-2553 | DOI: | 10.18632/oncotarget.21407 | SDG/關鍵字: | bevacizumab; core protein; messenger RNA; RNA; transcription factor AP 1; vasculotropin; angiogenesis; Article; binding site; cancer tissue; cell clone; controlled study; Hepatitis C virus; Huh-7 cell line; human; human cell; liver carcinogenesis; liver cell carcinoma; promoter region; protein expression; protein function; protein localization; tumor vascularization |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。